Sigma Healthcare Limited

( ASX:SIG ) - Health Care Equipment & Services


Analyst Views

SIG – UBS rates the stock as Sell

First half revenue was slightly weaker than expected. The main reasons were soft operating margins and higher costs for interest. The company has reiterated FY19 underlying EBIT guidance of $75m, which suggests to UBS that Sigma must now deliver a 45/55% earnings skew half on half to achieve this.

Read More